Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.67 Average Price Target from Brokerages

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) have received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $27.67.

A number of analysts recently issued reports on KMTS shares. Piper Sandler initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an “overweight” rating and a $27.00 price objective on the stock. Wolfe Research started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an “outperform” rating and a $29.00 price target on the stock. Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued a “buy” rating and a $28.00 price objective for the company. The Goldman Sachs Group assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set a “neutral” rating and a $24.00 target price on the stock. Finally, Wells Fargo & Company assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “overweight” rating and a $28.00 price target for the company.

Kestra Medical Technologies Price Performance

Shares of KMTS stock opened at $23.27 on Monday. Kestra Medical Technologies has a 1 year low of $20.00 and a 1 year high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.